contract
Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection
- Goal: Develop a concentrated intramuscular (IM) tranexamic acid (TXA) injection that can be delivered via prefilled syringe or dedicated autoinjector, and secure FDA approval for this formulation.
- Why it matters: TXA is used to control bleeding; a concentrated IM version in ready-to-use devices could enable faster, easier administration in emergency settings.
- Funding me…
Source
Agency: Administration For Strategic Preparedness And Response
Eligibility
government
Keywords
Tranexamic Acid (TXA)
Intramuscular injection
Prefilled syringe
Autoinjector
Hemorrhage control
Trauma care
FDA regulatory approval
Parenteral drug development
Military medicine
Antifibrinolytic therapy
Supporting Links
Sign up to unlock the source links
Sign up freeDocuments
Sign up to unlock the solicitation documents
Sign up freeSimilar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers